NPCE

NPCE

USD

Neuropace Inc. Common Stock

$11.145+0.045 (0.405%)

Real-time Price

Healthcare
Medical devices
United States

Price Chart

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$11.100

High

$11.280

Low

$10.890

Volume

0.00M

Company Fundamentals

Market Cap

368.5M

Industry

Medical devices

Country

United States

Trading Stats

Avg Volume

0.24M

Exchange

NGM

Currency

USD

52-Week Range

Low $5.45Current $11.145High $15.11

Related News

GlobeNewswire

NeuroPace Provides Update on Tariff Status

-- Minimal expected impact to operations and financial results -- -- Company to report first quarter 2025 financial results on May 13, 2025 -- MOUNTAIN VIEW, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc.

View more
NeuroPace Provides Update on Tariff Status
GlobeNewswire

NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting

MOUNTAIN VIEW, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (NASDAQ:NPCE), a medical device company focused on transforming the lives of people living with epilepsy, will be attending and presenting at

View more
NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting
GlobeNewswire

NeuroPace Announces Refocusing of Product Portfolio

-- Beginning of Wind Down of Stereo EEG (SEEG) Distribution Relationship in Q4 2025 -- -- Maintaining 2025 Revenue Guidance -- -- No Change to Long-Range Plan Expectations of Cash Flow Breakeven by the end of 2027 and

View more
NeuroPace Announces Refocusing of Product Portfolio
GlobeNewswire

NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference

MOUNTAIN VIEW, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (NASDAQ:NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management

View more
NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference